Malinda Itchins Clinical Oncology Society of Australia Annual Scientific Meeting 2022

Abstracts this author is presenting:

• Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: Analysis of all patients from VISION Cohorts A and C — Poster session 1
• Tepotinib + gefitinib in patients with EGFR-mutant NSCLC with MET amplification: final analysis of INSIGHT — Best of the Best Orals - Lung Cancer
• Medicine sequencing matters: drug sequencing for targeted therapies for NSCLC — Medicines Matter
• Genomics and the multidisciplinary team: hitting new targets — Hot topics in lung cancer